264 related articles for article (PubMed ID: 7799495)
1. Benefits and costs of screening and treatment for early breast cancer. Development of a basic benefit package.
Kattlove H; Liberati A; Keeler E; Brook RH
JAMA; 1995 Jan; 273(2):142-8. PubMed ID: 7799495
[TBL] [Abstract][Full Text] [Related]
2. Incidence of and treatment for ductal carcinoma in situ of the breast.
Ernster VL; Barclay J; Kerlikowske K; Grady D; Henderson C
JAMA; 1996 Mar; 275(12):913-8. PubMed ID: 8598618
[TBL] [Abstract][Full Text] [Related]
3. Cost-effectiveness of breast cancer screening in women on dialysis.
Wong G; Howard K; Chapman JR; Craig JC
Am J Kidney Dis; 2008 Nov; 52(5):916-29. PubMed ID: 18789566
[TBL] [Abstract][Full Text] [Related]
4. The patient burden of screening mammography recall.
Alcusky M; Philpotts L; Bonafede M; Clarke J; Skoufalos A
J Womens Health (Larchmt); 2014 Sep; 23 Suppl 1():S11-9. PubMed ID: 25247382
[TBL] [Abstract][Full Text] [Related]
5. [Health economics analysis of breast cancer screening].
Boncz I; Sebestyén A; Gulácsi L; Pál M; Dózsa C
Magy Onkol; 2003; 47(2):149-54. PubMed ID: 12975661
[TBL] [Abstract][Full Text] [Related]
6. Screening Mammography Program of British Columbia: pattern of use and health care system costs.
Olivotto IA; Kan L; Mates D; King S
CMAJ; 1999 Feb; 160(3):337-41. PubMed ID: 10065075
[TBL] [Abstract][Full Text] [Related]
7. Cost-effectiveness analysis of screening modalities for breast cancer in Japan with special reference to women aged 40-49 years.
Ohnuki K; Kuriyama S; Shoji N; Nishino Y; Tsuji I; Ohuchi N
Cancer Sci; 2006 Nov; 97(11):1242-7. PubMed ID: 16918992
[TBL] [Abstract][Full Text] [Related]
8. [Cost-benefit analysis of a mammography screening program extended to all the national territory].
Vanara F; Zappa M; Rosselli del Turco M; Segnan N; Paci E; Ponti A
Epidemiol Prev; 1997; 21(2):118-28. PubMed ID: 9378179
[TBL] [Abstract][Full Text] [Related]
9. Performance goals for an adjunct diagnostic test to reduce unnecessary biopsies after screening mammography: analysis of costs, benefits, and consequences.
Lee CI; Bensink ME; Berry K; Musa Z; Bodnar C; Dann R; Jarvik JG; Lehman CD; Ramsey SD
J Am Coll Radiol; 2013 Dec; 10(12):924-30. PubMed ID: 24295942
[TBL] [Abstract][Full Text] [Related]
10. Mammography screening: prospects and opportunity costs.
Navarro AM; Kaplan RM
Womens Health; 1996; 2(4):209-33. PubMed ID: 9421557
[TBL] [Abstract][Full Text] [Related]
11. Will early detection of breast cancer reduce the costs of treatment?
Salkeld G; Gerard K
Aust J Public Health; 1994 Dec; 18(4):388-93. PubMed ID: 7718652
[TBL] [Abstract][Full Text] [Related]
12. Cost-effectiveness of screening BRCA1/2 mutation carriers with breast magnetic resonance imaging.
Plevritis SK; Kurian AW; Sigal BM; Daniel BL; Ikeda DM; Stockdale FE; Garber AM
JAMA; 2006 May; 295(20):2374-84. PubMed ID: 16720823
[TBL] [Abstract][Full Text] [Related]
13. Breast cancer screening policies in developing countries: a cost-effectiveness analysis for India.
Okonkwo QL; Draisma G; der Kinderen A; Brown ML; de Koning HJ
J Natl Cancer Inst; 2008 Sep; 100(18):1290-300. PubMed ID: 18780864
[TBL] [Abstract][Full Text] [Related]
14. Preventive health care, 1999 update: 3. Follow-up after breast cancer. Canadian Task Force on Preventive Health Care.
Temple LK; Wang EE; McLeod RS
CMAJ; 1999 Oct; 161(8):1001-8. PubMed ID: 10551200
[TBL] [Abstract][Full Text] [Related]
15. Program-specific cost-effectiveness analysis: breast cancer screening policies for a safety-net program.
Melnikow J; Tancredi DJ; Yang Z; Ritley D; Jiang Y; Slee C; Popova S; Rylett P; Knutson K; Smalley S
Value Health; 2013; 16(6):932-41. PubMed ID: 24041343
[TBL] [Abstract][Full Text] [Related]
16. Understanding patient options, utilization patterns, and burdens associated with breast cancer screening.
Harvey SC; Vegesna A; Mass S; Clarke J; Skoufalos A
J Womens Health (Larchmt); 2014 Sep; 23 Suppl 1():S3-9. PubMed ID: 25247383
[TBL] [Abstract][Full Text] [Related]
17. Cost-effectiveness of mammography screening for breast cancer in a low socioeconomic group of Iranian women.
Barfar E; Rashidian A; Hosseini H; Nosratnejad S; Barooti E; Zendehdel K
Arch Iran Med; 2014 Apr; 17(4):241-5. PubMed ID: 24724599
[TBL] [Abstract][Full Text] [Related]
18. Costs of breast cancer and the cost-effectiveness of breast cancer screening.
Elixhauser A
Int J Technol Assess Health Care; 1991; 7(4):604-15. PubMed ID: 1778705
[TBL] [Abstract][Full Text] [Related]
19. Why question screening mammography for women in their forties?
Fletcher SW
Radiol Clin North Am; 1995 Nov; 33(6):1259-71. PubMed ID: 7480669
[TBL] [Abstract][Full Text] [Related]
20. United States Preventive Services Task Force screening mammography recommendations: science ignored.
Hendrick RE; Helvie MA
AJR Am J Roentgenol; 2011 Feb; 196(2):W112-6. PubMed ID: 21257850
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
